https://cureduchenne.org/resource-library/exon-skipping-and-read-through-agents-panel/
Exon Skipping and Read Through Agents Panel - CureDuchenne
exon skippingread throughagentspanelcureduchenne
https://edoc.mdc-berlin.de/id/eprint/24172/
Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse...
exon skippingand musclecellmediateddystrophin
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Antisense-oligonucleotide-induced-exon-skipping-restores-dystrophin/991005542206307891
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine...
Manipulation of pre-mRNA splicing by antisense oligonucleotides (AOs) offers considerable potential for a number of genetic disorders. One of these is Duchenne...
exon skippingrestoresdystrophinexpressionvitro
https://research.tees.ac.uk/en/projects/exon-skipping-for-nf1-phase-a/
Exon skipping for NF1 - Phase A - Teesside University's Research Portal
exon skippingteesside universityresearch portalphase
https://www.parentprojectmd.org/aiovg_videos/webinar-ns-pharma-overview-of-new-exon-skipping-trials-brogidirsen-and-ns-050-ncnp-03/page/28
Webinar: NS Pharma - Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03 - Parent...
NS Pharma joined PPMD on March 13, 2024 for a community webinar providing an overview of two new exon skipping trials: Brogidirsen (exon 44) and NS-050/NCNP-03...
exon skippingwebinarnspharmaoverview
https://pubmed.ncbi.nlm.nih.gov/21309043/
Prediction of single-nucleotide substitutions that result in exon skipping: identification of a...
Missense, nonsense, and translationally silent mutations can inactivate genes by altering the inclusion of mutant exons in mRNA, but their overall frequency...
exon skippingpredictionsinglenucleotidesubstitutions
https://repository.lib.ncsu.edu/items/515ddd86-b96e-4d82-825b-bbaa30de0fe3
Delivering Nucleic Acid Therapeutics: Investigations on Exon-skipping and Splice-switching or...
nucleic acid therapeuticsexon skippingdeliveringinvestigationssplice
https://mural.maynoothuniversity.ie/id/eprint/7494/
Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical...
exon skippingprofilingrevealsreversal
https://www.mdaconference.org/abstract-library/real-world-challenges-of-exon-skipping-treated-dmd-patients-one-centers-experience/
Real-world Challenges of Exon Skipping Treated DMD Patients; One Center's Experience - MDA Clinical...
Feb 27, 2023 - Duchenne Muscular Dystrophy (DMD) is an X-linked progressive muscle disease. Mutations in the DMD gene cause loss of the protein dystrophin. Without dystrophin...
real worldexon skippingchallengestreateddmd
https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17731045
Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin...
exon skippingintravenousinfusionresultsmuscle
https://uwcscholar.uwc.ac.za/items/e12131a2-b495-43df-8091-a568a6f9fb2b
Low detection of exon skipping in mouse genes orthologous to human genes on chromosome 22
Alternative RNA splicing is one of the leading mechanisms contributing towards transcript and protein diversity. Several alternative splicing surveys have...
exon skippinglowdetectionmousegenes
https://www.mda.org/science/professional-medical-education/industry-update-webinars/2026/novel-exon-skipping-therapies-for-patients-with-dmd-an-industry-update-from-entrada-therapeutics
Novel exon-skipping therapies for patients with DMD: An industry update from Entrada Therapeutics |...
Apr 16, 2026 - MDA is the #1 health nonprofit advancing research, care and advocacy for people living with muscular dystrophy, ALS, and related neuromuscular diseases.
exon skippingfor patientsindustry updatenoveltherapies
https://www.preprints.org/manuscript/202303.0389
Improved Prediction of Antisense Oligonucleotide Efficacy for Exon Skipping Using Ensemble Learning...
Antisense oligonucleotide (ASO)-mediated exon skipping has become a valuable tool for investigating gene function and developing gene therapy. Machine...
exon skippingensemble learningimprovedpredictionefficacy
https://pure.fujita-hu.ac.jp/ja/publications/tissue-specific-splicing-regulator-fox-1-induces-exon-skipping-by/
Tissue-specific splicing regulator Fox-1 induces exon skipping by interfering E complex formation...
exon skippingtissuespecificsplicingregulator
https://www.bioworld.com/articles/693154-entrada-selects-entr-601-45-as-development-candidate-for-dmd-patients-amenable-to-exon-45-skipping?v=preview
Entrada selects ENTR-601-45 as development candidate for DMD patients amenable to exon 45 skipping...
Entrada Therapeutics Inc. has selected a second clinical candidate within its Duchenne muscular dystrophy (DMD) franchise, ENTR-601-45, for the potential...
exon skippingentradaselectsdevelopmentcandidate
https://scholars.mssm.edu/en/publications/g-to-c-transversion-at-a-splice-acceptor-site-causes-exon-skippin-2/
G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene - Icahn...
exon skippingctransversionsiteb
https://digitalcommons.wustl.edu/oa_4/6110/
"BRCA1 secondary splice-site mutations drive exon-skipping and PARP inh" by Ksenija Nesic, John J...
PARP inhibitor (PARPi) therapy has transformed outcomes for patients with homologous recombination DNA repair (HRR) deficient ovarian cancers, for example...
exon skippingsecondarysplicesitemutations
https://www.spandidos-publications.com/or/34/5/2609
Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of...
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
exon skippingassociated withcancermutationsaffect
https://curelohealth.com/ghaziabad/test/met-exon-14-skipping-mutation-detection-1
MET Exon 14 Skipping Mutation Detection | Curelo
MET Exon 14 Skipping Mutation Detection
metexonskippingmutationdetection
https://connect.mayoclinic.org/discussion/therapy-for-metx14skipping-altetation/
Therapy for Lung Cancer with MET exon 14 Skipping mutation (METex14)? | Mayo Clinic Connect
Have been diagnosed with NSCLC 2021.Was treated with RT (SBRT) with resolution until 2023, when multiple ground glass lesions were found on followup CT/PET s...
lung cancermayo clinictherapymetexon
https://www.trialx.com/clinical-trials/listings/322896/a-study-in-participants-with-duchenne-muscular-dystrophy-amenable-to-exon-44-skipping-to-evaluate-the-safety-and-efficacy-of-entr-601-44/
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate...
Clinical trial for Duchenne Muscular Dystrophy (DMD) , A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the...
duchenne muscular dystrophystudyparticipantsamenableexon
https://digitalcommons.providence.org/publications/8253/
"Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping M" by N Leighl, Rachel...
Introduction: Amivantamab, an epidermal growth factor receptor (EGFR)/ mesenchymal-epithelial transition factor (MET) bispecific antibody with immune...
in patientsadvanced nsclcmetexonskipping